IP-10 induces dissociation of newly formed blood vessels

Journal of Cell Science

Volumn 122, Issue 12, 2009, Pages 2064-2077

  Bodnar, Richard J ^a,b   Yates, Cecelia C ^b   Rodgers, Margaret E ^a   Du, Xiaoping ^c   Wells, Alan ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Angiogenesis; Chemokines; Endothelial cells; Integrin; Wound healing

Indexed keywords

BETA3 INTEGRIN; CALPAIN; CALPAIN 1; CASPASE 3; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; 5(4' HYDROXYBENZYLIDENOIMINO) 3 METHYLISOTHIAZOLO(5,4 D)PYRIMIDINE (7H) 4,6 DIONE; 5(4'-HYDROXYBENZYLIDENOIMINO)-3-METHYLISOTHIAZOLO(5,4-D)PYRIMIDINE-(7H)-4,6-DIONE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CXCR3 PROTEIN, MOUSE; MU-CALPAIN; PYRIMIDINONE DERIVATIVE; THIAZOLE DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL DEATH; CONTROLLED STUDY; DISSOCIATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WOUND HEALING; ANIMAL; BLOOD VESSEL; C57BL MOUSE; CELL ADHESION; CELL CULTURE; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

MUS;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD VESSELS; CALPAIN; CELL ADHESION; CELL DEATH; CELLS, CULTURED; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; PYRIMIDINONES; RECEPTORS, CXCR3; SIGNAL TRANSDUCTION; THIAZOLES;

EID: 68949181600     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.048793     Document Type: Article

References (40)

1. Ades, E. W., Candal, F. J., Swerlick, R. A., George, V. G., Summers, S., Bosse, D. C. and Lawley, T. J. (1992). HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99, 683-690.
2. Benjamin, L. E., Golijanin, D., Itin, A., Pode, D. and Keshet, E. (1999). Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Invest. 103, 159-165.
3. Bodnar, R. J., Yates, C. C. and Wells, A. (2006). IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circ. Res. 98, 617-625.
4. Booth, V., Keizer, D. W., Kamphuis, M. B., Clark-Lewis, I. and Sykes, B. D. (2002). The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry 41, 10418-10425.
5. Brunner, G. and Blakytny, R. (2004). Extracellular regulation of TGF-beta activity in wound repair: growth factor latency as a sensor mechanism for injury. Thromb. Haemost. 92, 253-261.
6. Burdick, M. D., Murray, L. A., Keane, M. P., Xue, Y. Y., Zisman, D. A., Belperio, J. A. and Strieter, R. M. (2005). CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. Am. J. Respir. Crit. Care Med. 171, 261-268.
7. Carmeliet, P., Lampugnani, M. G., Moons, L., Breviario, F., Compernolle, V., Bono, F., Balconi, G., Spagnuolo, R., Oosthuyse, B., Dewerchin, M. et al. (1999). Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98, 147-157.
8. Davis, G. E. and Saunders, W. B. (2006). Molecular balance of capillary tube formation versus regression in wound repair: role of matrix metalloproteinases and their inhibitors. J. Invest. Dermatol. Symp. Proc. 11, 44-56.
9. Feldman, E. D., Weinreich, D. M., Carroll, N. M., Burness, M. L., Feldman, A. L., Turner, E., Xu, H. and Alexander, H. R., Jr (2006). Interferon gamma-inducible protein 10 selectively inhibits proliferation and induces apoptosis in endothelial cells. Ann. Surg. Oncol. 13, 125-133.
10. Flevaris, P., Stojanovic, A., Gong, H., Chishti, A., Welch, E. and Du, X. (2007). A molecular switch that controls cell spreading and retraction. J. Cell Biol. 179, 553-565.
11. Giese, N. A., Raykov, Z., DeMartino, L., Vecchi, A., Sozzani, S., Dinsart, C., Cornelis, J. J. and Rommelaere, J. (2002). Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice. Cancer Gene Ther. 9, 432-442.
12. Glading, A., Bodnar, R. J., Reynolds, I. J., Shiraha, H., Satish, L., Potter, D. A., Blair, H. C. and Wells, A. (2004). Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol. Cell. Biol. 24, 2499-2512.
13. Greenberg, J. I., Shields, D. J., Barillas, S. G., Acevedo, L. M., Murphy, E., Huang, J., Schepple, L., Stockmann, C., Johnson, R. S., Angle, N. et al. (2008). A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456, 809-813.
14. Hancock, W. W., Lu, B., Gao, W., Csizmadia, V., Faia, K., King, J. A., Smiley, S. T., Ling, M., Gerard, N. P. and Gerard, C. (2000). Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192, 1515-1520.
15. Jimenez, B., Volpert, O. V., Crawford, S. E., Febbraio, M., Silverstein, R. L. and Bouck, N. (2000). Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6, 41-48.
16. Kouroumalis, A., Nibbs, R. J., Aptel, H., Wright, K. L., Kolios, G. and Ward, S. G. (2005). The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate G alpha i-independent signaling and actin responses in human intestinal myofibroblasts. J. Immunol. 175, 5403-5411.
17. Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E. et al. (2003). An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197, 1537-1549.
18. Lazzeri, E. and Romagnani, P. (2005). CXCR3-binding chemokines: novel multifunctional therapeutic targets. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5, 109-118.
19. Lobov, I. B., Rao, S., Carroll, T. J., Vallance, J. E., Ito, M., Ondr, J. K., Kurup, S., Glass, D. A., Patel, M. S., Shu, W. et al. (2005). WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437, 417-421.
20. Mahabeleshwar, G. H., Feng, W., Reddy, K., Plow, E. F. and Byzova, T. V. (2007). Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ. Res. 101, 570-580.
21. Meredith, J., Jr, Mu, Z., Saido, T. and Du, X. (1998). Cleavage of the cytoplasmic domain of the integrin beta3 subunit during endothelial cell apoptosis. J. Biol. Chem. 273, 19525-19531.
22. Nyberg, P., Xie, L. and Kalluri, R. (2005). Endogenous inhibitors of angiogenesis. Cancer Res. 65, 3967-3979.
23. Perrin, B. J. and Huttenlocher, A. (2002). Calpain. Int. J. Biochem. Cell Biol. 34, 722-725.
24. Piper, K. P., Horlock, C., Curnow, S. J., Arrazi, J., Nicholls, S., Mahendra, P., Craddock, C. and Moss, P. A. (2007). CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-hist disease in the skin following allogeneic stem-cell transplantation, Blood 110, 3827-3832.
25. Rehn, M., Veikkola, T., Kukk-Valdre, E., Nakamura, H., Ilmonen, M., Lombardo, C., Pihlajaniemi, T., Alitalo, K. and Vuori, K. (2001). Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA 98, 1024-1029.
26. Romagnani, P., Annunziato, F., Lasagni, L., Lazzeri, E., Beltrame, C., Francalanci, M., Uguccioni, M., Galli, G., Cosmi, L., Maurenzig, L. et al. (2001). Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107, 53-63.
27. Salcedo, R., Resau, J. H., Halverson, D., Hudson, E. A., Dambach, M., Powell, D., Wasserman, K. and Oppenheim, J. J. (2000). Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J. 14, 2055-2064.
28. Satish, L., Blair, H. C., Glading, A. and Wells, A. (2005). Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain. Mol. Cell. Biol. 25, 1922-1941.
29. Shiraha, H., Glading, A., Chou, J., Jia, Z. and Wells, A. (2002). Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol. Cell. Biol. 22, 2716-2727.
30. Struyf, S., Burdick, M. D., Peeters, E., Van den Broeck, K., Dillen, C., Proost, P., Van Damme, J. and Strieter, R. M. (2007). Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis. Cancer Res. 67, 5940-5948.
31. Tait, C. R. and Jones, P. F. (2004). Angiopoietins in tumours: the angiogenic switch. J. Pathol. 204, 1-10.
32. Tarui, T., Miles, L. A. and Takada, Y. (2001). Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells. J. Biol. Chem. 276, 39562-39568.
33. Tsubaki, T., Takegawa, S., Hanamoto, H., Arita, N., Kamogawa, J., Yamamoto, H., Takubo, N., Nakata, S., Yamada, K., Yamamoto, S. et al. (2005). Accumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts. Clin. Exp. Immunol. 141, 363-371.
34. Xi, X., Bodnar, R. J., Li, Z., Lam, S. C. and Du, X. (2003). Critical roles for the COOH-terminal NITY and RGT sequences of the integrin beta3 cytoplasmic domain in inside-out and outside-in signaling. J. Cell Biol. 162, 329-339.
35. Xi, X., Flevaris, P., Stojanovic, A., Chishti, A., Phillips, D. R., Lam, S. C. and Du, X. (2006). Tyrosine phosphorylation of the integrin beta 3 subunit regulates beta 3 cleavage by calpain. J. Biol. Chem. 281, 29426-29430.
36. Yamaguchi, K., Ogawa, K., Katsube, T., Shimao, K., Konno, S., Shimakawa, T., Yoshimatsu, K., Naritaka, Y., Yagawa, H. and Hirose, K. (2005). Platelet factor 4 gene transfection into tumor cells inhibits angiogenesis, tumor growth and metastasis. Anticancer Res. 25, 847-851.
37. Yang, J. and Richmond, A. (2004). The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan. Mol. Ther. 9, 846-855.
38. Yao, L., Pike, S. E., Pittaluga, S., Cherney, B., Gupta, G., Jaffe, E. S. and Tosato, G. (2002). Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin. Cancer Immunol. Immunother. 51, 358-366.
39. Yates, C. C., Whaley, D., Kulasekeran, P., Hancock, W. W., Lu, B., Bodnar, R., Newsome, J., Hebda, P. A. and Wells, A. (2007). Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. Am. J. Pathol. 171, 484-495.
40. Yates, C. C., Whaley, D., Y-Chen, A., Kulesekaran, P., Hebda, P. A. and Wells, A. (2008). ELR-negative CXC chemokine CXCL11 (IP-9/ITAC) facilitates dermal and epidermal maturation during wound repair. Am. J. Pathol. 173, 643-652.